Publicaciones (29) Publicaciones de JORGE NAVARRO DORADO

2023

  1. The bitter taste receptor (TAS2R) agonist denatonium promotes a strong relaxation of rat corpus cavernosum

    Biochemical Pharmacology, Vol. 215

  2. The novel KV7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit

    Biomedicine and Pharmacotherapy, Vol. 164

2022

  1. In vitro inhibition of phosphodiesterase type 4 enhances rat corpus cavernosum nerve-mediated relaxation induced by gasotransmitters

    Life Sciences, Vol. 296

2021

  1. Teaching urinary system anatomy and physiology in an integrated virtual environment with a problem-based learning (pbl)

    EduLearn 21 Proceedings: 13th International Conference on Education and New Learning Technologies Online Conference. 5-6 July, 2021.

2019

  1. The cell-wide web coordinates cellular processes by directing site-specific Ca2+ flux across cytoplasmic nanocourses

    Nature Communications, Vol. 10, Núm. 1

2016

  1. AMP-activated protein kinase deficiency blocks the hypoxic ventilatory response and thus precipitates hypoventilation and apnea

    American Journal of Respiratory and Critical Care Medicine, Vol. 193, Núm. 9, pp. 1032-1043

  2. From contraction to gene expression: nanojunctions of the sarco/endoplasmic reticulum deliver site- and function-specific calcium signals

    Science China Life Sciences, Vol. 59, Núm. 8, pp. 749-763

  3. Vascular dysfunction in a transgenic model of Alzheimer's disease: Effects of CB1R and CB2R cannabinoid agonists

    Frontiers in Neuroscience, Vol. 10, Núm. SEP

2014

  1. Age-dependent defective TGF-beta1 signaling in patients undergoing coronary artery bypass grafting

    Journal of Cardiothoracic Surgery, Vol. 9, Núm. 1

  2. Calcium oscillations in human mesenteric vascular smooth muscle

    Biochemical and Biophysical Research Communications, Vol. 445, Núm. 1, pp. 84-88

2012

  1. Decreased pre-surgical CD34 +/CD144 + cell number in patients undergoing coronary artery bypass grafting compared to coronary artery disease-free valvular patients

    Journal of Cardiothoracic Surgery, Vol. 7, Núm. 1

  2. Denosumab en el tratamiento de la osteoporosis posmenopáusica y de la pérdida de masa ósea en pacientes con deprivación androgénica

    Actualidad en farmacología y terapéutica, Vol. 10, Núm. 1, pp. 17-27

  3. La depleción de células CD34 +/CD144 + en pacientes de revascularización miocárdica no está mediada por un aumento de la apoptosis inducida por el TGF-beta plasmático

    Clinica e Investigacion en Arteriosclerosis, Vol. 24, Núm. 1, pp. 12-20

  4. La depleción de células CD34+/CD144+ en pacientes de revascularización miocárdica no está mediada por un aumento de la apoptosis inducida por el TGF-beta plasmático

    Actualidad en farmacología y terapéutica, Vol. 10, Núm. 4, pp. 226-232

  5. La depleción de células CD34+/CD144+ en pacientes de revascularización miocárdica no está mediada por un aumento de la apoptosis inducida por el TGF-beta plasmático

    Clínica e investigación en arteriosclerosis, Vol. 24, Núm. 1, pp. 12-20

  6. The complex regulation of TGF-β in cardiovascular disease

    Vascular Health and Risk Management, Vol. 8, Núm. 1, pp. 533-539

2011

  1. Diosgenin modulates vascular smooth muscle cell function by regulating cell viability, migration, and calcium homeostasis

    Journal of Pharmacology and Experimental Therapeutics, Vol. 336, Núm. 3, pp. 925-939

  2. Overproduction of cyclo-oxygenase-2 (COX-2) is involved in the resistance to apoptosis in vascular smooth muscle cells from diabetic patients: A link between inflammation and apoptosis

    Diabetologia, Vol. 54, Núm. 1, pp. 190-199

  3. Pharmacological basis and clinical evidence of dabigatran therapy

    Journal of Hematology and Oncology, Vol. 4

2010

  1. A comparative study of α-adrenergic receptor mediated Ca2+ signals and contraction in intact human and mouse vascular smooth muscle

    European Journal of Pharmacology, Vol. 629, Núm. 1-3, pp. 82-88